Literature DB >> 17713008

Myeloid-derived suppressor cells.

Srinivas Nagaraj1, Dmitry I Gabrilovich.   

Abstract

The development of tumor-specific T cell tolerance is largely responsible for tumor escape. Accumulation of myeloid-derived suppressor cells (MDSCs) in animal tumor models as well as in cancer patients is involved in tumor-associated T cell tolerance. In recent years, it has become increasingly evident that MDSCs bring about antigen-specific T cell tolerance by various mechanisms, which is the focus of this chapter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713008     DOI: 10.1007/978-0-387-72005-0_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  57 in total

1.  Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

Authors:  Wentao Jia; Colleen Jackson-Cook; Martin R Graf
Journal:  J Neuroimmunol       Date:  2010-05-08       Impact factor: 3.478

2.  Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.

Authors:  Baisakhi Raychaudhuri; Patricia Rayman; Joanna Ireland; Jennifer Ko; Brian Rini; Ernest C Borden; Jorge Garcia; Michael A Vogelbaum; James Finke
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

3.  Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.

Authors:  Michael P Gustafson; Yi Lin; Kent C New; Peggy A Bulur; Brian Patrick O'Neill; Dennis A Gastineau; Allan B Dietz
Journal:  Neuro Oncol       Date:  2010-02-23       Impact factor: 12.300

4.  Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.

Authors:  Emily C Bellavance; Frederick J Kohlhapp; Andrew Zloza; Jeremy A O'Sullivan; James McCracken; Michael C Jagoda; Andrew T Lacek; Mitchell C Posner; Jose A Guevara-Patino
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

5.  Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

Authors:  Andrea Facciabene; Xiaohui Peng; Ian S Hagemann; Klara Balint; Andrea Barchetti; Li-Ping Wang; Phyllis A Gimotty; C Blake Gilks; Priti Lal; Lin Zhang; George Coukos
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

Review 6.  The role of natural killer cells in curbing neuroinflammation.

Authors:  Benjamin M Segal
Journal:  J Neuroimmunol       Date:  2007-09-29       Impact factor: 3.478

7.  Induction of myeloid-derived suppressor cells by tumor exosomes.

Authors:  Xiaoyu Xiang; Anton Poliakov; Cunren Liu; Yuelong Liu; Zhong-bin Deng; Jianhua Wang; Ziqiang Cheng; Spandan V Shah; Gui-Jun Wang; Liming Zhang; William E Grizzle; Jim Mobley; Huang-Ge Zhang
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  The immune privileged retina mediates an alternative activation of J774A.1 cells.

Authors:  Chun H Lau; Andrew W Taylor
Journal:  Ocul Immunol Inflamm       Date:  2009 Nov-Dec       Impact factor: 3.070

9.  Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.

Authors:  Stephanie K Watkins; Bing Li; Katharine S Richardson; Kimberly Head; Nejat K Egilmez; Qun Zeng; Jill Suttles; Robert D Stout
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

10.  Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression.

Authors:  S Peter Bak; Anselmo Alonso; Mary Jo Turk; Brent Berwin
Journal:  Mol Immunol       Date:  2008-09-27       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.